Page last updated: 2024-11-01

nimodipine and Infant, Newborn, Diseases

nimodipine has been researched along with Infant, Newborn, Diseases in 2 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
McGowan, B1
Khaira, G1
Coghlan, MA1
Shaibani, A1
Alden, TD1
Pardo, AC1
Pei, LN1
Liu, XH1
Zhang, H1
Zhu, J1
Gao, Z1
Bi, MZ1

Other Studies

2 other studies available for nimodipine and Infant, Newborn, Diseases

ArticleYear
Use of Nimodipine in a Neonate With Cerebral Vasospasm With Delayed Ischemia From Subarachnoid Hemorrhage in the Posterior Fossa.
    Pediatric neurology, 2020, Volume: 111

    Topics: Angiography, Digital Subtraction; Brain Ischemia; Cerebral Angiography; Cranial Fossa, Posterior; Hu

2020
Clinical efficacy of mouse nerve growth factor plus nimodipine in neonatal intracranial hemorrhage and its effect on plasma PAF, CNP, MMP-2, and neurological function.
    European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:1

    Topics: Animals; Humans; Infant, Newborn; Infant, Newborn, Diseases; Injections, Intramuscular; Intracranial

2021